Meet Olaparib: A Key Player in the Fight Against Cancer By Steve|2024-10-13T19:19:08+13:00July 2nd, 2024|Categories: All, Drug Reviews, Z-Legacy|Tags: olaparib, PARP Inhibitor| Read More 0
Treatment options improving for Cholangiocarcinoma By Steve|2024-10-11T16:12:25+13:00October 15th, 2018|Categories: All, Immunotherapy, Z-Legacy|Tags: ABC-02, ARID1A, BAP1, BAY1436032, BRAF, BRCA1/2, Chemotherapy, Cyramza, dmmr, EGFR, epigenetic, FGFR2, Gem/Cis, GENOME, HER2 amplification, IDH1, IDH1/2, immunotherapy, Kelly, KEYNOTE-158, Keytruda, Lynparza, MEK, MET, MMR, olaparib, Oncologists, ramucirumab, TAS-120, TP53, treatment, TreeTopp, VEGFR, VEGFR2| Read More 0